Retraction: Enhancer RNA SLIT2 inhibits bone metastasis of breast cancer through regulating P38 MAPK/c-Fos signaling pathway - Takeaways - MDSpire

Retraction: Enhancer RNA SLIT2 inhibits bone metastasis of breast cancer through regulating P38 MAPK/c-Fos signaling pathway

  • May 7, 2026

  • 0 min

Share

  • 1

    The article on enhancer RNA SLIT2's role in breast cancer bone metastasis has been retracted due to image integrity concerns.

  • 2

    Image duplication issues were identified in Figures 8 and 9, leading to questions about the reliability of the data.

  • 3

    The authors did not provide a satisfactory explanation during the investigation, resulting in the article's retraction.

  • 4

    The retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor.

  • 5

    This retraction acknowledges the concerns raised by Sholto David regarding the integrity of the published article.

Original Source(s)

Related Content